The Epigenetics Market is projected to register a CAGR of 13.5% during the forecast period (2017–2022). The Epigenetics Market is growing and the experts have predicted the future stats of Epigenetics. Epigenetics Market report contains the top corporate profiles and strategies with industry analysis and trends.
Complete report is now available on Epigenetics Market by Product (Kit, Enzymes, Reagent, NGS, Mass Spectrometer, PCR, Bioinformatics), Application (Oncology, Cardiology, Immunology), Technology (DNA Methylation, Histone Modification), End User (Academic, CRO) – Global Forecast to 2022at http://www.rnrmarketresearch.com/epigenetics-technology-market-epigenomics-dna-methylation-histone-modifications-rna-interference-cancer-therapeutics-personalized-medicine-2012-2017-market-report.html
The global epigenetics market is projected to reach USD 1,605.7 million by 2022 from USD 854.0 million in 2017, at a CAGR of 13.5% during the forecast period. The decreasing sequencing costs and time, increasing research activities, favorable funding scenario for epigenetics research, rising prevalence of cancer are the key factors driving market growth during the forecast period. On the other hand, the high cost of instruments is expected to restrain the growth of this market to a certain extent.
On the basis of application, the epigenetics market is segmented into oncology, metabolic diseases, developmental biology, immunology, cardiovascular diseases, and other applications (includes neurology, gynecology, and infectious diseases). In 2016, the oncology segment accounted for the major share of the global epigenetics market. The large share of this segment is attributed to the rising prevalence of cancer and the increasing number of research-related activities.
Get Discount on Epigenetics Market Report at http://www.rnrmarketresearch.com/contacts/discount?rname=68045
Break of primary participants in Epigenetics Market was as mentioned below:
By company type: Tier 1 – 35%, Tier 2 – 45%, and Tier 3 – 20%
By designation: C-level – 35%, Director level – 25%, and Others – 40%
By region: North America – 48%, Europe – 22%, APAC – 22%, Latin America –4%, and MEA–4%
Major players of Epigenetics Market Report are:
The prominent players in the epigenetics market include Illumina (US), Thermo Fisher (US), Diagenode (Belgium), QIAGEN (Netherlands), Merck Millipore (US), Abcam (UK), Active Motif (US), New England Biolabs (US), Agilent (US), Zymo Research (US), PerkinElmer (US), and Bio-Rad (US).
FAQ’s regarding the Epigenetics Market Report are:
Market Penetration of Epigenetics Market Report:
Comprehensive information on the product portfolios of the top players in the Epigenetics market
Product Development/Innovation of Epigenetics Market Report:
Detailed insights on the upcoming technologies, R&D activities, and product launches in the Epigenetics market
Competitive Assessment of Epigenetics Market Report:
In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the Epigenetics market
Market Development of Epigenetics Market Report:
Comprehensive information about emerging markets. This report analyzes the market for various Epigenetics products across geographies
Market Diversification of Epigenetics Market Report:
Exhaustive information about new products, untapped geographies, recent developments, and investments in the Epigenetics market
Get Brochure of this report before ordering a copy of Epigenetics Market at http://www.rnrmarketresearch.com/contacts/request-sample?rname=68045
On the basis of end users, the epigenetics market is segmented into academic and research institutes, pharmaceutical and biotechnology companies, and contract research organizations (CROs). The pharmaceutical and biotechnology companies segment is expected to register the highest CAGR during the forecast period, owing to increasing research in the areas of genomics with a strong focus on personalized medicine.
The global epigenetics market is broadly segmented into five major regions, namely, North America, Europe, Asia Pacific (APAC), Latin America, and the Middle East & Africa. North America accounted for the largest share of the global epigenetics market in 2016, while Asia Pacific is projected to register the highest growth rate during the forecast period. Factors such as increasing R&D spending, favorable government initiatives, and rising focus ofkey market players on enhancing their presence in this region are supporting the growth of the epigenetics market in the Asia Pacific.
On an unrelated note, another research titled with Universal Flash Storage Market by Capacity (32 GB, 64 GB, 128 GB, 256 GB, 512 GB), Configuration, End Use (Automotive Electronics, Digital cameras, Gaming Consoles, High-Resolution Displays, Smartphones), Application, and Geography – Global Forecast to 2023. The universal flash storage market is estimated to grow from USD 3.59 billion in 2017 and is estimated to reach USD 9.97 billion by 2023, at a CAGR of 18.6% during 2017–2023. Now available at http://www.rnrmarketresearch.com/universal-flash-storage-market-by-capacity-32-gb-64-gb-128-gb-256-gb-512-gb-configuration-end-use-automotive-electronics-digital-cameras-gaming-consoles-high-resolution-displays-smartphones-applicatio-st-to-2023-market-report.html
About us: RnRMarketResearch.com is your single source for all market research needs. Our database includes 100,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.